HENOCH-SCHONLEIN PURPURALI HASTALARIN ANALİZİ

Year 2006, Volume: 7 Issue: 3, 39 - 43, 01.12.2006

Maşallah Candemir Hülya Halis Aziz Polat Hacer Ergin İlknur Kılıç Serap Semiz Mine Cinbiş

Abstract

Amaç:HSP'li hastalarımızın epidemiyolojik ve klinik özellikleri, laboratuar bulguları ve hastalığın seyrininincelenmesi amaçlandı.Yöntem:2000-2006 yılları arasında, hastanemiz Çocuk Sağlığı ve Hastalıkları Kliniği'nde Henoch-SchonleinPurpurası tanısı alan ve izlenen 45 hasta retrospektif olarak incelendi.Bulgular:Hastaların 27 (%60,0)'si kız, 18 (%40,0)'i erkek, kız / erkek oranı 1.5 idi. Yaş ortalaması 6 yaş 9 ay (8ay-14 yaş) olarak saptandı. Başvuru şikayetleri sıklık sırasına göre döküntü (%100), yürüyememe ve/veya eklemağrısı (%71,1) ve karın ağrısı (%40,0) idi. Hastaların % 57,7'inde ortalama 12 gün önce geçirilmiş enfeksiyonöyküsü tespit edildi. Fizik muayenede purpurik döküntü (alt ekstremite ve gluteal bölgede %100, yaygın %11,1),artrit (32 hastada, %71,1, en sık ayak bileği ve diz eklemlerinde), ateş (9 hastada, %20,0) bulundu. Laboratuarbulguları anemi (8/45 hasta, %17,7), lökositoz (6/45 hasta, %13,3), trombositoz (16/45 hasta, %35,5),sedimentasyon yüksekliği (16/25 hasta, %64,0), CRP pozitifliği (33/34 hasta, %97,0), hematüri (4/45 hasta,%8,8), proteinüri (2/45 hasta, %,4,4), gaitada gizli kan pozitifliği (14/42 hasta, %33,3) bulundu. Hematüri veproteinüri devam etmediği için hiçbir hastada böbrek biyopsisine gerek duyulmadı. Gastrointestinal sistemtutulumu olduğu düşünülen 17 hastaya steroid tedavisi başlandı ve ortalama 9.1 gün kullanıldı. Perforasyon,invaginasyon gözlenmedi. Ortalama 15. günde 9 hastada relaps görüldü. Santral sinir sistemi tutulumu hiçbirhastada yoktu.Sonuç:Henoch-Schonlein Purpurası çocukluk çağında sık görülen benign karakterli bir hastalık olupkomplikasyon ve sekel oranı oldukça düşüktür

Keywords

Henoch-Schönlein purpurası, vaskülit

Analysis of Patients With Henoch-Schönlein Purpura

Abstract

Aim: The aim of this study was to investigate the clinical and epidemiologic features, laboratory finding and outcome of disease in our patients with Henoch-Schönlein purpura. Methods: Fourty-five patients with Henoch-Schönlein purpura who were diagnosed and observed in our department of pediatrics between 2000-2006 were retrospectively evaluated. Results: Twentyseven (60.0%) of the patients were female and 18 (40.0%) were male, female to male ratio was1.5. Mean age of the patients was 6 year 9 months (8 months-14 years). İnitial symptoms and findings in the time of admission with decreasing frequency were purpura (100%), disability to walk and/or arthralgia (71.1%) ve stomachache (40.0%). An infection history was present in 57.7% of the patients in the last 12 days. In physical examination, purpura (lower extremity and hips 100%, diffuse 11.1%), arhtritis (32 patients, 71.1%, mostly diffused on ankle and knee), fever (9 patients, 20,0%) were discovered. Anaemia (8/45 patients, 17.7%), leukocytosis (6/45 patients, 13.3%), trombocytosis (16/45 patients, 35.5%), increased erythrocyte sedimentation rate (16/25 patients, 64.0%), positive CRP (33/34 patients, 97.0%), hematuria (4/45 patients, 8.8%), proteinuria (2/45 patients, 4.4%), positive fecal blood tests (14/42 patients, 33.3%) were determined. Renal biopsy was not needed as there was no persistant hematuria and proteinuria. 17 patients who had gastrointestinal involvement were treated with steroid therapy for a mean period of 9.1 days. Perforation and invagination was not observed. Relapse was seen in 9 patients. (mean duration 15th day). There was no nervous system involvement in any patients. Conclusion: Henoch-Schonlein Purpura is a frequent benign disease of childhood. Complicatios and sequeles are infrequent.

Keywords

Henoch-Schönlein purpura, vasculitis

References

• 1. Ozen S, Bakkaloglu A, Dusunsel R, Soylemezoglu O, Ozaltin F, Poyrazoglu H. et all. Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol 2006: Apr 4.
• 2. Michael LM, Lauren MP. Vasculitis syndromes. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed, Philadelphia: WB Saunders Co, 2004: 826-9.
• 3. Kim S, Dedeoglu F. Update on pediatric vasculitis. Curr Opin Pediatr 2005; 17:695-702.
• 4. Tsuboi H, Takemura T, Katsuoka K. A case of HenochSchonlein purpura temporarily improved by hemodialysis. J Dermatol. 2006; 33:281-6.
• 5. Ilan Y, Naparstek Y. Henoch Schonlein purpura in children and adults: Is it one entity?. Semin Arthritis Rheum 2002; 32:139-40.
• 6. Soylu A, Kavukçu S. Henoch-Schönlein purpura in childhood: Pathophysiology, diagnosis and treatment. SSK Tepecik Hast Derg 2004; 14:71-81.
• 7. Sandra T, Annalisa M, Francesca G, Massimo R. et all. Henoch-Schonlein purpura in childhood: Epidemiological and clinical analysis of 150 cases over a 5-year period and review of Literature. Semin Arthritis Rheum 2005; 35:143-53.
• 8. Szer IS. Henoch-Schonlein purpura. Curr Opin Rheumatol 1994; 6:25-31.
• 9. Altinkaynak S, Ertekin V, Selimoglu MA. J Emer Med. 2006; 30:21921.
• 10. Tizard EJ. Henoch-Schoenlein purpura. Arch Dis Child 1999; 80:3803.
• 11. Aydın M, Demirol M, Kurt A, Kurt NAC, Yılmaz E. The evaluation of the our patients with HenochSchönlein purpura. Çocuk Dergisi 2005; 5:249-53.
• 12. Kaku Y, Nohara K, Honda S. Renal involvement in Schonlein-Henoch Purpura: a multivariate analysis of prognostic factors. Kidney Int 1998; 53:1755-59.
• 13. Kendirli T, Yalcinkaya F, Ileri M, Ozcakar ZB, Ekim E. HenochSchonlein purpura in Turkish children. Journal ofAnkara Medical School. 2004; 26: 7-11
• 14. Rosenblum ND, Winter HS. Steroid effects on the course of abdominal pain in children with HenochSchonlein Purpura. Pediatrics 1987; 79:1018-21.
• 15. Glasier CM, Siegel MJ, Mc Alister WH, Shackelford GD. Henoch Schonlein syndrome in children: gastrointestinal manifestations. Am J Roentgenol 1981; 136:1081-5.
• 16. Ballinger S. HenochSchonlein Purpura. Curr Opin Rheumatol 2003; 15:5914.
• 17. Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Jeong HJ. HenochSchönlein purpura nephritis with nephroticrange proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment Scand J Rheumatol 2005; 34:3925.
• 18. Gonzalez-Gay MA, Llorca J. Controversies on the use of corticosteroid therapy in children with Henoch Schönlein purpura. Semin Arthritis Rheum 2005; 35:135-7.